Treatment of Multiple Myeloma Using Chimeric Antigen Receptor T Cells with Dual Specificity.
Globerson Levin A, Rawet Slobodkin M, Waks T, Horn G, Ninio-Many L, Deshet Unger N, Ohayon Y, Suliman S, Cohen Y, Tartakovsky B, Naparstek E, Avivi I, Eshhar Z.
Globerson Levin A, et al. Among authors: horn g.
Cancer Immunol Res. 2020 Dec;8(12):1485-1495. doi: 10.1158/2326-6066.CIR-20-0118. Epub 2020 Oct 2.
Cancer Immunol Res. 2020.
PMID: 33008840